Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice.
Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice. J Am Soc Nephrol. 2003 Mar; 14(3):670-9.